Watch! The ADDRESS-LC Trial Webinar

The ADDRESS-LC trial was designed to assess the potential impact of bezisterim on cognitive impairment/brain fog and fatigue in individuals with Long Covid and is currently recruiting people aged 18-64 […]

Guest Blog: COVID, Vax, RFK Jr.—What’s Next?

Guest blog by David R. Kotok and Elizabeth Sweet The Kotok Report is now also available on Substack at https://dkotok.substack.com.  As we have watched over the last few months the canceling […]

Skip to content